- Clone
- H131 (See other available formats)
- Regulatory Status
- RUO
- Other Names
- T cell receptor Vβ13.1 chain, TCRBV13.1, TCRBV13
- Isotype
- Mouse IgG2b, κ
- Barcode Sequence
- TTATGGACGTATGGT
Cat # | Size | Price | Quantity Check Availability | ||
---|---|---|---|---|---|
362415 | 10 µg | $369.00 |
TCR Vβ13.1 is a variant of the TCR β chain. The receptor is complexed with the TCR α chain and belongs to the immunoglobulin superfamily. It is expressed on a subset of T cells and some T cell clones. Variability in the β chain is generated by Vβ, Dβ, and Jβ gene rearrangement, while variability in the α chain is generated by Vα and Jα rearrangement. TCR Vβ13.1 has been shown to be related to antigen recognition and inflammation as well as diseases, such as HIV and multiple sclerosis.
Product Details
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- Mouse T cell hybridoma
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
- Preparation
- The antibody was purified by chromatography and conjugated with TotalSeq™-B oligomer under optimal conditions.
- Concentration
- 0.5 mg/mL
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
- Application
-
PG - Quality tested
- Recommended Usage
-
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis and the oligomer sequence is confirmed by sequencing. TotalSeq™-B antibodies are compatible with 10x Genomics Single Cell Gene Expression Solutions.
To maximize performance, it is strongly recommended that the reagent be titrated for each application, and that you centrifuge the antibody dilution before adding to the cells at 14,000xg at 2 - 8°C for 10 minutes. Carefully pipette out the liquid avoiding the bottom of the tube and add to the cell suspension. For Proteogenomics analysis, the suggested starting amount of this reagent for titration is ≤ 1.0 µg per million cells in 100 µL volume. Refer to the corresponding TotalSeq™ protocol for specific staining instructions.
Buyer is solely responsible for determining whether Buyer has all intellectual property rights that are necessary for Buyer's intended uses of the BioLegend TotalSeq™ products. For example, for any technology platform Buyer uses with TotalSeq™, it is Buyer's sole responsibility to determine whether it has all necessary third party intellectual property rights to use that platform and TotalSeq™ with that platform. - Application Notes
-
Additional reported applications (for the relevant formats of this clone) include: activation of TCR Vβ13.1 expressing cells1.
- Additional Product Notes
-
TotalSeq™ reagents are designed to profile protein levels at a single cell level following an optimized protocol similar to the CITE-seq workflow. A compatible single cell device (e.g. 10x Genomics Chromium System and Reagents) and sequencer (e.g. Illumina analyzers) are required. Please contact technical support for more information, or visit biolegend.com/totalseq.
The barcode flanking sequences are GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNNNNNNNN (PCR handle), and NNNNNNNNNGCTTTAAGGCCGGTCCTAGC*A*A (capture sequence). N represents either randomly selected A, C, G, or T, and * indicates a phosphorothioated bond, to prevent nuclease degradation.
View more applications data for this product in our Scientific Poster Library. -
Application References
(PubMed link indicates BioLegend citation) -
- Choi YW, et al. 1991. Proc. Natl. Acad. Sci. USA 88:8357.
- RRID
-
AB_2888780 (BioLegend Cat. No. 362415)
Antigen Details
- Structure
- Immunoglobulin superfamily
- Distribution
-
Subset of T cells
- Function
- Antigen recognition, activation of TCR Vβ13.1 bearing T cells
- Ligand/Receptor
- Peptide bound MHC molecules
- Cell Type
- T cells
- Biology Area
- Adaptive Immunity, Immunology
- Molecular Family
- TCRs
- Antigen References
-
1. Hong J, et al. 1999. J. Immunol. 163:3530.
2. Jason J, et al. 1997. Scand. J. Immunol. 45:81.
3. Chang JC, et al. 1995. Ann. NY. Acad. Sci. 756:370.
4. Miyahara E, et al. 1999. Anticancer Res. 19:2057.
5. Usuku K, et al. 1993. Immunogenetics. 38:193.
6. Bakakos P, et al. 2002. Clin. Exp. Immunol. 129:370. - Gene ID
- 6957 View all products for this Gene ID
- UniProt
- View information about TCR Vbeta13.1 on UniProt.org
Other Formats
View All TCR Vβ13.1 Reagents Request Custom ConjugationDescription | Clone | Applications |
---|---|---|
Purified anti-human TCR Vβ13.1 | H131 | FC,Activ |
FITC anti-human TCR Vβ13.1 | H131 | FC |
PE/Cyanine7 anti-human TCR Vβ13.1 | H131 | FC |
APC anti-human TCR Vβ13.1 | H131 | FC |
PE anti-human TCR Vβ13.1 | H131 | FC |
TotalSeq™-C0908 anti-human TCR Vβ13.1 | H131 | PG |
TotalSeq™-B0908 anti-human TCR Vβ13.1 Antibody | H131 | PG |
Compare Data Across All Formats
This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.